(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

E-STAR BIOTECH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

E-STAR BIOTECH

ST13

US500000090822938

Class

5, 42, 44

Filing

90822938

Registration

8128287

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

45

Latest update

02/04/2026

Trademark type

Word

Nice classes

5, 42, 44

Filing date

07/12/2021

Registration date

02/03/2026

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

02/03/2026

Last transaction

02/04/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2024-10-00

First use in commerce

2024-10-00

Drawing code

4

Owner type

16

Owner location

New York, NY

Examiner

MCBRIDE,CAMERON L

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

E-Star BioTech, LLC

Representatives

Paul C. Llewellyn ARNOLD & PORTER KAYE SCHOLER LLP

Technical classification

Nice Classes

Class 5Class 42Class 44

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceuticals for the treatment of metabolic diseases; pharmaceuticals for the regulation of the endocrine system; pharmaceuticals for the treatment of cardiovascular diseases; pharmaceuticals for the treatment of hypertension

Class 42

Pharmaceutical drug development services; biomedical research services; pharmaceutical research services; consulting services in the fields of biotechnology and pharmaceutical research and development; providing information in the fields of biotechnology and pharmaceutical research; providing scientific information in the field of biotechnology and pharmaceutical research and development

Class 44

Providing medical information in the field of biotechnology and pharmaceutical research and development

Publications

History of USPTO decisions and trademark events.

45 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

02/03/2026

R.PR

REGISTERED-PRINCIPAL REGISTER

02/03/2026

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

01/12/2026

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

01/12/2026

SUPC

STATEMENT OF USE PROCESSING COMPLETE

12/23/2025

IUAF

USE AMENDMENT FILED

12/18/2025

EISU

TEAS STATEMENT OF USE RECEIVED

12/18/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

11/27/2025

EX5G

SOU EXTENSION 5 GRANTED

11/26/2025

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

11/26/2025

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/08/2025

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/08/2025

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/08/2025

EXT5

SOU EXTENSION 5 FILED

10/07/2025

EEXT

SOU TEAS EXTENSION RECEIVED

06/09/2025

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/03/2025

EX4G

SOU EXTENSION 4 GRANTED

12/03/2024

EXT4

SOU EXTENSION 4 FILED

12/02/2024

EEXT

SOU TEAS EXTENSION RECEIVED

12/02/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/28/2024

EX3G

SOU EXTENSION 3 GRANTED

06/28/2024

EXT3

SOU EXTENSION 3 FILED

06/28/2024

EEXT

SOU TEAS EXTENSION RECEIVED

06/28/2024

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

12/14/2023

EX2G

SOU EXTENSION 2 GRANTED

12/12/2023

EXT2

SOU EXTENSION 2 FILED

12/12/2023

EEXT

SOU TEAS EXTENSION RECEIVED

12/12/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

06/29/2023

EX1G

SOU EXTENSION 1 GRANTED

06/27/2023

EXT1

SOU EXTENSION 1 FILED

06/27/2023

EEXT

SOU TEAS EXTENSION RECEIVED

06/27/2023

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

01/03/2023

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

11/08/2022

PUBO

PUBLISHED FOR OPPOSITION

11/08/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

10/19/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

10/03/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

09/19/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

09/19/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

09/19/2022

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

04/06/2022

GNRT

NON-FINAL ACTION E-MAILED

04/06/2022

CNRT

NON-FINAL ACTION WRITTEN

04/06/2022

DOCK

ASSIGNED TO EXAMINER

03/30/2022

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/16/2021

NWAP

NEW APPLICATION ENTERED

07/15/2021

Continuous trademark protection

Get notified about every new filing that threatens E-STAR BIOTECH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.